Manufacture of bulk drugs at the heart of what we do
India’s first company to start commercial production of Anti-tuberculosis drug Rifampicin
Gujarat Themis Biosyn Limited was incorporated in 1981 as a joint sector company with GIIC Ltd. and Chemosyn (P) Ltd. It commenced production in August 1985. It was subsequently taken over in June 1991 by Yuhan Group, South Korea and Pharmaceutical Business Group (India) Ltd. (PBG); a unique consortium of five competing drug companies - Themis Medicare Ltd., Kopran Ltd., Anant & Co., Cadila Health Care Ltd. (Zydus) and Lyka Labs Ltd. It is being actively managed by Themis Medicare Ltd. (JV company of Gedeon Richter Ltd, Hungary) since 2007.
News Corner
2025-03-26 19:17:00 - Intimation of Closure of Trading Window for the Quarter and Financial year ending 31st March, 2025
2025-02-28 10:22:13 - Memorandum & Articles of Association
2025-02-21 18:15:49 - Intimation about Listing of Equity shares of the Company on the NationalStock Exchange of India Limited (“NSE”)
2025-01-03 07:41:00 - Change in name of Registrar and Share Transfer Agent of the Company
2024-12-27 03:00:00 - Intimation of Closure of Trading Window for the quarter ending on 31st December, 2024
Annual Report 2022 – 2023